Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Radiation Injuries × Pentetic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Radiation Injuries 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Hodgkin Disease 1

Interventions

Radiotherapy 4 Paclitaxel 3 Cisplatin 3 Amifostine 3 sodium propionate 1 ethanethiol 1 Topotecan 1 Radiation Protection 1 Pentetic Acid 1 Filgrastim 1 Fatty Acids, Volatile 1 Etoposide 1 Daclizumab 1 Carboplatin 1 Butyric Acid 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00019227 2013-06-20

Monoclonal Antibody Therapy in Treating Patients With Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Radiation Injuries, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡